Partnering

Pantherna Therapeutics is seeking for diverse types of collaborations with pharmaceutical and biotech companies.

The Company plans to partner its inhouse development programs at the pre-clinical or clinical stage.
In addition, Pantherna is interested in research collaborations and pre-clinical development agreements with industry partners to extend the applications of Pantherna’s proprietary lipid nanoparticle mRNA expression technology platforms (PTX_LNP®, PTXmRNA®).
Pantherna is open to research agreements with academia and biotech that have complementary research interest and corresponding capabilities in selected indications proposed by the respective partner.

Individuals or organizations interested in exploring potential collaboration opportunities are invited to contact:
Dr. Klaus Giese, CEO
k.giese@pantherna-therapeutics.com